Accessibility Menu
 
Quantum-Si Incorporated logo

Quantum-Si Incorporated

(NASDAQ) QSI

Current Price$0.78
Market Cap$167.47M
Since IPO (2020)-92%
5 Year-94%
1 Year-36%
1 Month-19%

Quantum-Si Incorporated Financials at a Glance

Market Cap

$167.47M

Revenue (TTM)

$2.44M

Net Income (TTM)

$101.34M

EPS (TTM)

$-0.52

P/E Ratio

-1.50

Dividend

$0.00

Beta (Volatility)

2.15 (High)

Price

$0.78

Volume

80

Open

$0.76

Previous Close

$0.78

Daily Range

$0.76 - $0.79

52-Week Range

$0.73 - $3.10

QSI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Quantum-Si Incorporated

Industry

Life Sciences Tools and Services

Employees

145

CEO

Jeffrey Alan Hawkins, MBA

Headquarters

Guilford, CT 06437, US

QSI Financials

Key Financial Metrics (TTM)

Gross Margin

-1%

Operating Margin

-48%

Net Income Margin

-42%

Return on Equity

-47%

Return on Capital

-52%

Return on Assets

-41%

Earnings Yield

-66.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$167.47M

Shares Outstanding

216.37M

Volume

80

Short Interest

0.00%

Avg. Volume

4.20M

Financials (TTM)

Gross Profit

$3.30M

Operating Income

$97.05M

EBITDA

$92.59M

Operating Cash Flow

$94.72M

Capital Expenditure

$2.52M

Free Cash Flow

$97.23M

Cash & ST Invst.

$162.91M

Total Debt

$4.17M

Quantum-Si Incorporated Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$451.00K

-62.2%

Gross Profit

$4.33M

-810.2%

Gross Margin

-9.61%

N/A

Market Cap

$167.47M

N/A

Market Cap/Employee

$1.12M

N/A

Employees

149

N/A

Net Income

$17.61M

+46.8%

EBITDA

$19.92M

+32.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$158.74M

-19.3%

Accounts Receivable

$561.00K

-57.9%

Inventory

$3.20M

-21.4%

Long Term Debt

$2.32M

-74.9%

Short Term Debt

$1.84M

-50.1%

Return on Assets

-41.26%

N/A

Return on Invested Capital

-52.16%

N/A

Free Cash Flow

$16.33M

+32.8%

Operating Cash Flow

$16.35M

+28.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALTAltimmune, Inc.
$3.08+6.94%
ENGNenGene Holdings Inc.
$6.81+10.19%
AUTLAutolus Therapeutics plc
$1.38+8.66%
RCKTRocket Pharmaceuticals, Inc.
$3.58+3.92%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.15+0.09%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$80.49-0.10%
IBITiShares Bitcoin Trust
$38.42+0.02%

Questions About QSI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.